Mar 30
Medtronic Voluntary February Recall for BioGlide® Ventricular Snap Shunt Catheters
Manufacturing , RecallsMedtronic, Inc. announced that the U.S. Food and Drug Administration (FDA) classified as Class I its voluntary recall action initiated on February 11, 2009 of its BioGlide® Ventricular Snap Shunt Catheter (Cat. #s 27782, 27708 and 27802) – the cerebral ventricular catheter component of a shunt for the treatment of hydrocephalus.

Recent Comments